ePrints

[¹⁸F] Fluciclatide PET as a biomarker of clinical response to combination therapy of pazopanib and paclitaxel in patients with platinum-resistant or platinum-refractory advanced ovarian cancer: Results of a phase Ib study

Lookup NU author(s): Dr Jingky Lozano-KuehneORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Sharma R, Valls PO, Inglese M, Dubash SR, Chen M, Gabra H, Montes A, Challapalli A, Tharakan G, Chambers E, Cole T, Lozano-Kuehne J, Barwick T, Aboagye E

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Oncology

Year: 2019

Volume: 37

Issue: 15_suppl

Print publication date: 20/05/2019

Online publication date: 26/05/2019

Acceptance date: 20/05/2019

ISSN (print): 0732-183X

ISSN (electronic): 1527-7755

Publisher: American Society of Clinical Oncology

URL: https://doi.org/10.1200/JCO.2019.37.15_suppl.3070

DOI: 10.1200/JCO.2019.37.15_suppl.3070

Altmetrics

Share